Roche Urges Fed. Circ. To Revive Boniva Patents
According to Roche’s brief, U.S. District Judge Stanley R. Chesler had mistakenly ruled that the company’s patents covering Boniva — U.S. Patent Numbers 7,718,634 and 7,410,957 — could have been anticipated based on studies involving lower doses of the drug and were thus obvious.
To view the full article, register now.